Long-term follow-up in composite tissue allotransplantation: in-depth study of five (hand and face) recipients
- PMID: 21446980
- DOI: 10.1111/j.1600-6143.2011.03469.x
Long-term follow-up in composite tissue allotransplantation: in-depth study of five (hand and face) recipients
Abstract
Composite tissue allotransplantations (CTAs) have clinically shown little, if any, evidence of chronic rejection. Consequently, the effect of chronic rejection on bones, joints, nerves, muscles, tendons and vessels may still have undescribed implications. We thoroughly assessed all allograft structures by histology, magnetic resonance imaging, ultrasonography and high resolution peripheral quantitative computed tomography scan in four bilateral hand-grafted patients (10, 7, 3 and 2 years of follow-up, respectively) and in one facial allotransplantation (5 years of follow-up). All the recipients presented normal skin structure without dermal fibrosis. Vessels were patent, without thrombosis, stenosis or intimal hyperplasia. Tendons and nerves were also normal; muscles showed some changes, such as a variable degree of muscular hypotrophy, particularly of intrinsic muscles, accompanied by fatty degeneration that might be related to denervation. In the majority of hand-grafted patients graft radius and recipient tibia showed a decrease in trabecular density, although in the graft radius the alterations also involved the cortices. No deterioration of graft function was noted. In these cases of CTA no signs of chronic graft rejection have been detected. However, the possibility that chronic rejection may develop in CTA exists, highlighting the necessity of close continuous follow-up of the patients.
©2011 The Authors Journal compilation©2011 The American Society of Transplantation and the American Society of Transplant Surgeons.
Similar articles
-
The International Registry on Hand and Composite Tissue allotransplantation.Clin Transpl. 2011:247-53. Clin Transpl. 2011. PMID: 22755418
-
Swine hemi-facial composite tissue allotransplantation: a model to study immune rejection.J Surg Res. 2009 May 15;153(2):268-73. doi: 10.1016/j.jss.2008.03.050. Epub 2008 Apr 28. J Surg Res. 2009. PMID: 18708190
-
The Significance of Vascular Alterations in Acute and Chronic Rejection for Vascularized Composite Allotransplantation.J Vasc Res. 2019;56(4):163-180. doi: 10.1159/000500958. Epub 2019 Jul 2. J Vasc Res. 2019. PMID: 31266018 Review.
-
Outcomes after bilateral hand allotransplantation: a risk/benefit ratio analysis.Ann Surg. 2015 Jan;261(1):213-20. doi: 10.1097/SLA.0000000000000627. Ann Surg. 2015. PMID: 24646555
-
Extracorporeal photopheresis: from solid organs to face transplantation.Transpl Immunol. 2009 Jul;21(3):117-28. doi: 10.1016/j.trim.2009.04.005. Epub 2009 May 3. Transpl Immunol. 2009. PMID: 19409991 Review.
Cited by
-
Current status of vascularized composite tissue allotransplantation.Burns Trauma. 2014 Apr 6;2(2):53-60. doi: 10.4103/2321-3868.130184. eCollection 2014. Burns Trauma. 2014. PMID: 27602363 Free PMC article.
-
Longitudinal immunological characterization of the first presensitized recipient of a face transplant.JCI Insight. 2017 Jul 6;2(13):e93894. doi: 10.1172/jci.insight.93894. eCollection 2017 Jul 6. JCI Insight. 2017. PMID: 28679959 Free PMC article.
-
Sensitization and Desensitization in Vascularized Composite Allotransplantation.Front Immunol. 2021 Aug 11;12:682180. doi: 10.3389/fimmu.2021.682180. eCollection 2021. Front Immunol. 2021. PMID: 34456906 Free PMC article. Review.
-
The Future of Microsurgery: Vascularized Composite Allotransplantation and Engineering Vascularized Tissue.J Hand Microsurg. 2024 Apr 16;16(1):100011. doi: 10.1055/s-0042-1757182. eCollection 2024 Mar. J Hand Microsurg. 2024. PMID: 38854368 Free PMC article.
-
Upper extremity composite tissue allotransplantation imaging.Eplasty. 2013 Jul 16;13:e38. eCollection 2013. Eplasty. 2013. PMID: 23943677 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical